Press
Die Gesundmacher aus dem Großkapital
Mehr Impfstoffe, bessere Krebstherapien und neue Medikamente gegen seltene Krankheiten...der Schlüssel dazu in der Hightech-Finanzwelt liegt.
Search
10541 - 10550 out of 10562
Press
Tech innovations can help fight COVID – if we do our part
“...artificial intelligence (AI) has played an important role in helping...battle the health crisis, but technology can only do so much.”
Press
Why public health messaging should emphasize vaccine acceptance, not hesitancy
"...our research highlights how overstating or overemphasizing hesitancy can, by itself, keep others from getting vaccinated."
Press
Ways to solve the social media crisis
Sinan Aral discusses ways companies can monitor the spread of misinformation online, and how to protect privacy and data on social media.
Press
Closing the COVID trust deficit
"Economists have developed an emerging body of evidence that...may also help to improve delivery and increase uptake of COVID-19 vaccines.”
Press
How the pandemic is changing Big Pharma
“...can Big Pharma learn from the lessons of the pandemic and adopt a platform more akin to software development than drug development?”
Press
Out of grief, MIT's Andrew Lo invented a better way to finance biomedical innovation
“Finance plays a huge role, sometimes way too big a role, in how drugs get developed."
Press
Vaccination is not enough
"Eradication will be a long haul. Combining vaccination, testing, and other mitigation measures is essential to getting there."
Press
Latest MIT COVID-19 data tracking model for Connecticut projects more hospitalizations, deaths into March
“It has correctly predicted second waves, not only in Connecticut but around the world..."
Why It’s So Hard to Cut Waste in Health Care
Why It’s So Hard to Cut Waste in Health Care
Professor Finkelstein: If something becomes more expensive, people will buy less of it. When patients have to pay more, they use less medical care. The problem is they use less of all types of care.